Browsing eNauka
Browsing by Author Poddubskaya, Elena
Showing results 1 to 5 of 5
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2021 | Bevacizumab biosimilar (MB02) and reference bevacizumab in patients with stage IIIB/IV non-squamous non-small cell lung cancer (NSCLC) (STELLA study): Multiple Imputation analysis. | Trukhin, Dmytro; Poddubskaya, Elena; Andric, Zoran G   ; Bondarenko, Igor N; Shevnia, Serhii; Zaric, Bojan ; Bellala, Ravishankar; Charoentum, Chaiyut; Perez, Luis; Bullo, Felicitas;
Garcia, Fernanda;
| Conference Paper | Mp. category will be shown later |
| 2020 | Bevacizumab biosimilar and reference bevacizumab in subjects with stage IIIB/IV no squamous non-small cell lung cancer (NSCLC) (STELLA study): Results for the primary endpoint in a confirmatory, double-blind, randomized, controlled study. | Millan, Susana; Trukhin, Dmytro; Kolesnik, Oleksii; Poddubskaya, Elena; Andric, Zoran G ; Bondarenko, Igor N; Shevnia, Serhii; Bullo, Felicitas; Sarnago, Cristina | Conference Paper | Mp. category will be shown later |
| 2023 | Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non–Small-Cell Lung Cancer: Results From LASER301 | Cho, Byoung Chul; Ahn, Myung-Ju; Kang, Jin Hyoung; Soo, Ross A.; Reungwetwattana, Thanyanan; Yang, James Chih-Hsin; Cicin, Irfan; Kim, Dong-Wan; Wu, Yi-Long; Lu, Shun;
Lee, Ki Hyeong; Pang, Yong-Kek; Zimina, Anastasia; Fong, Chin Heng; Poddubskaya, Elena; Sezer, Ahmet; How, Soon Hin; Danchaivijitr, Pongwut; Kim, YuKyung; Lim, Yeji; An, Taewon; Lee, Hana; Byun, Hae Mi; Zaric, Bojan
; | Article | 21a+M21a+ |
| 2018 | Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer | Van, Cutsem Eric; Hidalgo, Manuel; Canon, Jean-Luc; Macarulla, Teresa; Bazin, Igor; Poddubskaya, Elena; Manojlović, Nebojša S. ; Radenkovic, Dejan V; Verslype, Chris; Eric, Raymond;
Cubillo, Antonio; Schueler, Armin; Zhao, Charles; Hammel, Pascal;
| Article | 21aM21a |
| 2015 | Phase II randomized trial of MEK inhibitor pimasertib or placebo combined with gemcitabine in the first-line treatment of metastatic pancreatic cancer. | Van, Cutsem Eric; Hidalgo, Manuel; Bazin, Igor; Canon, Jean-Luc; Poddubskaya, Elena; Manojlović, Nebojša S ; Milella, Michele; Radenkovic, Dejan V; Verslype, Chris; Guo, Wei;
Damstrup, Lars; Hammel, Pascal;
| Conference Paper | Mp. category will be shown later |